| 000 | a | ||
|---|---|---|---|
| 999 | _c11282 _d11282 | ||
| 003 | OSt | ||
| 005 | 20200215084722.0 | ||
| 008 | 200215b xxu||||| |||| 00| 0 eng d | ||
| 040 | _aAIKTC-KRRC _cAIKTC-KRRC | ||
| 100 | _912300 _aKottakki, Naveen Kumar | ||
| 245 | _aSYNTHESIS AND ANTIBACTERIAL ACTIVITY OF PIPERAZINE ANALOGUES CONTAINING [1, 3, 4]-OXADIAZOLE RING | ||
| 250 | _aVol.57(01), Jan | ||
| 260 | _aMumabi _bIndian Drug Manufacture's Association - IDMA _c2020 | ||
| 300 | _a19-26p. | ||
| 520 | _aA new series of piperazine-1, 3, 4-oxadiazole deviatives were synthesized by the condensation of 1, 3, 4-thidaizole with substituted piperazine, in the presence of N, N-diisopropylethylamine. The structures were confirmed by IR, 1H NMR, 13C NMR and Mass spectroscopy. All the precursors were screened for anti-bacterial activity and the results indicate that phenyl substituted chloro (PO2) and hydroxy (PO6) functional derivatives possess better anti-bacterial activity towards to Gram-positive bacteria and gram-negative bacteria, Maximum zone of inhibition was observed in (PO2) against Bacillus subtillus (14.0 mm) and (PO6) against Pseudomonas aeruginosa (14.0 mm). Piperazine-1, 3, 4-oxadiazoles were synthesized by combining two active molecules into a new bioactive conjugate molecule. These new hybrid molecules have more potential biological activity than their parent molecules | ||
| 650 | 0 | _94639 _aPHARMACEUTICS | |
| 700 | _912301 _aSoujanya Kumari, P. V. D. | ||
| 773 | 0 | _dMumbai Indian Drug Manufactures Association _tIndian drugs | |
| 856 | _uhttps://www.indiandrugsonline.org/issuesarticle-details?id=MTAxMA== _yClick here | ||
| 942 | _2ddc _cAR | ||